| Adam Clemente Gonzalez, MD | |
|
4505 Alberta Ave, El Paso, TX 79905-2727 | |
| (915) 532-1447 | |
| Not Available |
| Full Name | Adam Clemente Gonzalez |
|---|---|
| Gender | Male |
| Speciality | Pathology - Forensic Pathology |
| Location | 4505 Alberta Ave, El Paso, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477045219 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | BP10063421 (Texas) | Secondary |
| 207ZF0201X | Pathology - Forensic Pathology | T4926 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Adam Clemente Gonzalez, MD 4505 Alberta Ave, El Paso, TX 79905-2727 Ph: () - | Adam Clemente Gonzalez, MD 4505 Alberta Ave, El Paso, TX 79905-2727 Ph: (915) 532-1447 |
News Archive
Medimetrics, recently certified to ISO 13485, has successfully developed the IntelliCap system, specifically designed to target delivery of small molecule drugs and biologics to the gastrointestinal (GI) tract. The technology is capable of achieving controlled release of drugs to specific GI sites in a fast, cost-effective and convenient manner (Shimizu et al., 2008).
Discovery Laboratories, Inc., a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced that the United States Food and Drug Administration (FDA) has approved SURFAXIN (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants at high risk for RDS.
Reflecting the benefit from a stronger yen/dollar exchange rate and lower realized investment losses, total revenues rose 15.5% to $5.0 billion in the second quarter of 2010, compared with $4.3 billion in the second quarter of 2009. Net earnings were $581 million, or $1.23 per diluted share, compared with $314 million, or $.67 per share, a year ago.
Dermal fibroblasts are specialized cells deep in the skin that generate connective tissue and help the skin recover from injury. Some fibroblasts have the ability to convert into fat cells that reside under the dermis, giving the skin a plump, youthful look and producing a peptide that plays a critical role in fighting infections.
Virtual Radiologic Corporation, a national radiology practice and a leader in the development of radiologist workflow technology, and Providence Equity Partners, a leading global private equity firm that manages over $22 billion in equity capital, today announced that they have entered into a definitive agreement under which Providence will acquire all of the outstanding common stock of vRad for $17.25 per share in cash.
› Verified 7 days ago
Osvaldo Padilla, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2001 North Oregon Street, Department Of Pathology, El Paso, TX 79902 Phone: 915-577-7316 Fax: 915-577-7345 | |
Harry Lee Wilson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2001 North Oregon Street, Pathology Dept, El Paso, TX 79902 Phone: 915-577-6011 | |
Daniel Bustamante, MD Pathology Medicare: Medicare Enrolled Practice Location: 4815 Alameda Ave, El Paso, TX 79905 Phone: 915-215-4956 | |
Cynthia Reyes Barron, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1301 E River Ave, El Paso, TX 79902 Phone: 915-533-3000 | |
Dr. Darius A. Boman, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 4815 Alameda Ave, El Paso, TX 79905 Phone: 915-521-7415 Fax: 915-521-7920 | |
Hector Zepeda, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 10301 Gateway West, Department Of Pathology, El Paso, TX 79925 Phone: 915-595-9299 Fax: 915-595-9786 | |
Dr. Janice Mariel Diaz, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 4505 Alberta Ave, El Paso, TX 79905 Phone: 915-532-1447 |